Supreme court
Supreme Court Orders Centre to Take Action Against Black Marketing of COVID-19 Medicines
The Supreme Court of India has ordered the Centre to take action against black marketing of COVID-19 medicines. The court observed that the black marketing of COVID-19 medicines is a serious issue that requires immediate attention, and that the Centre should take immediate action to prevent it. The judgment was delivered by a three-judge bench comprising Justices D.Y. Chandrachud, L. Nageswara Rao, and S. Ravindra Bhat. The court held that the Centre should take immediate action to prevent the black marketing of COVID-19 medicines, and that the states should also take action to ensure that COVID-19 medicines are available to all patients at a reasonable price. The court also observed that the Centre should take action to prevent the hoarding of COVID-19 medicines and to ensure that they are available to all patients in a timely and transparent manner. The judgment has significant implications for the Centre and the states. The court's decision to order the Centre to take action against black marketing of COVID-19 medicines is a significant development that will have far-reaching consequences for the country. The judgment is a testament to the court's commitment to upholding the right to health and ensuring that the citizens have access to adequate medical care. The court's emphasis on the importance of preventing the black marketing of COVID-19 medicines is a significant development that will shape the contours of public health and healthcare in India. The judgment is expected to have significant implications for the future of public health and healthcare in India, and it is expected to be a major milestone in the development of the right to health in the country. The court's decision will have significant implications for the Centre and the states, and it is expected to be a major development in the ongoing debate over public health and healthcare in India. The judgment is a significant development that will have far-reaching consequences for the country, and it is expected to be a major milestone in the development of the right to health in India.
